IRCT2017080520715N3招募中3 期
The Effect of Aprepitant on Chemo-Induced Nausea and Vomiting in Children with Cancer
Vice chancellor for research, Arak University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 5 years 至 18 years（—）
- 性别
- All
入选标准
- •Inclusion Criteria: Patients with malignancies who was under chemotherapy with 5 to 18 years of age; non-nausea due to illness with the approval of the physician; presence of a healthy vision; attending the first day of chemotherapy and nausea severity; minimum score of 20 From VAS mm100 (visual analogue scale).
- •Exclusion criteria: Severe manifestations of complications of the epiphyte including fever, severe infection, tinnitus, deep vein thrombosis, severe digestive problems, etc; failure of the patient to determine the severity of nausea based on the instructions.
排除标准
- 未提供
研究者
相似试验
已完成
不适用
ow emetic chemotherapy induced nausea and vomiting: A prospective, multicenter, observational studyJPRN-UMIN000020800Commitee of academic, society of pharmacist in national hospital organization kyushu200
已完成
不适用
Decreasing the Incidence of Post-Operative Nausea and Vomiting (PONV) in Bariatric PatientsNauseaVomitingNCT00956215University of Pennsylvania125
已完成
2 期
Aprepitant as Antiemetic Prophylaxis in Patients With Acute Myeloid Leukemia Undergoing Induction ChemotherapyAcute Myeloid LeukemiaNCT01334086University Health Network, Toronto41
已完成
2 期
Efficacy of Aprepitant for Hematology and Oncology.Hematological malignanciesJPRN-UMIN000009702Kyoto University Hospital,Department of Hematology and Oncology30
已完成
不适用
Efficacy of aprepitant on postoperative nausea and vomiting: Assesement with patient-controlled prevention of nause and vomiting (PCPNV).Patients undergoing dento-oral surgeryJPRN-UMIN000004167Tohoku University Graduate School of Dentistry40